Eaderm

Eaderm

Innovative stem cell therapies for skin and hair, enhancing health and longevity.

HQ location
Tokyo, Japan
Website
Launch date
Enterprise value
$2—2m
  • Edit
loading funding rounds…
More about Eaderm
Made with AI
Edit

Eaderm is a pioneering biotech company specializing in advanced stem cell therapies aimed at treating skin and hair conditions. Operating in the healthcare and biotechnology sectors, Eaderm focuses on research and development of innovative medical solutions to improve patient outcomes and quality of life. The company primarily serves patients suffering from dermatological conditions, leveraging cutting-edge science and tissue engineering techniques to offer effective treatments. Eaderm's business model revolves around the commercialization of its proprietary therapies, generating revenue through product sales and potential licensing agreements. The recent funding of 50 million yen from ANRI underscores investor confidence in Eaderm's growth potential and innovative approach. The company is committed to advancing healthcare solutions that not only address immediate medical needs but also contribute to long-term health and well-being.

Keywords: stem cell therapy, dermatology, biotechnology, healthcare, tissue engineering, skin treatment, hair treatment, medical innovation, patient care, Japan.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads